Brent Egan to Drug Resistance
This is a "connection" page, showing publications Brent Egan has written about Drug Resistance.
Connection Strength
1.687
-
Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2017 Mar; 19(3):241-249.
Score: 0.527
-
Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension. J Am Soc Hypertens. 2013 Jan-Feb; 7(1):95-101.
Score: 0.405
-
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug 30; 124(9):1046-58.
Score: 0.367
-
Role of aldosterone blockade in resistant hypertension. Semin Nephrol. 2014 May; 34(3):273-84.
Score: 0.111
-
NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am J Hypertens. 1991 Dec; 4(12 Pt 1):924-31.
Score: 0.094
-
Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets? Curr Opin Cardiol. 2011 Jul; 26(4):300-7.
Score: 0.091
-
Overnight rostral fluid shift and obstructive sleep apnea in treatment resistant hypertension: connecting the dots clarifies the picture. Hypertension. 2010 Dec; 56(6):1040-1.
Score: 0.087
-
Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med. 1990 Feb 15; 112(4):270-7.
Score: 0.005